Excitingly, further functional assays validated the hypothesis that KHDC1L could promote cell viability and inhibit apoptosis in CAL27, distinguishing as a promising specific target for the diagnosis and treatment of HNSCC. The gene discussed is KHDC1L; the disease is head and neck squamous cell carcinoma.